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Abstract
Mutations in the Opo gene result in eye malformation in medaka fish. The human ortholog of this gene, MRDS1/OFCC1,i sa
potentially causal gene for orofacial cleft, as well as a susceptibility gene for schizophrenia, a devastating mental illness.
Based on this evidence, we hypothesized that this gene could perform crucial functions in the development of head and
brain structures in vertebrates. To test this hypothesis, we created Mrds1/Ofcc1-null mice. Mice were examined thoroughly
using an abnormality screening system referred to as ‘‘the Japan Mouse Clinic’’. No malformations of the head structure, eye
or other parts of the body were apparent in these knockout mice. However, the mutant mice showed a marked increase
in serum c-glutamyl transpeptidase (GGT), a marker for liver damage, but no abnormalities in other liver-related
measurements. We also performed a family-based association study on the gene in schizophrenia samples of Japanese
origin. We found five single nucleotide polymorphisms (SNPs) located across the gene that showed significant transmission
distortion, supporting a prior report of association in a Caucasian cohort. However, the knockout mice showed no
behavioral phenotypes relevant to schizophrenia. In conclusion, disruption of the Mrds1/Ofcc1 gene elicits asymptomatic
hyper-c-glutamyl-transpeptidasemia in mice. However, there were no phenotypes to support a role for the gene in the
development of eye and craniofacial structures in vertebrates. These results prompt further examination of the gene,
including its putative contribution to hyper-c-glutamyl transpeptidasemia and schizophrenia.
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Introduction
Genetic studies have implicated the Mrds1/Ofcc1/Opo gene in
multiple developmental processes although its biological function
remains largely unknown. Martinez-Morales et al. identified a
medaka (a small fish similar to zebrafish) mutant, ojoplano (opo),
which is defective in optic cup morphogenesis, and identified the
gene responsible for this phenotype. In addition to the defective
optic cup, opo mutants also show aberrant craniofacial develop-
ment and deficits in other structures, including the brain. The gene
product of medaka Opo is strikingly similar to that of the
mammalian MRDS1/OFCC1/Mrds1/Ofcc1 gene [1], suggesting a
function in vertebrate eye and craniofacial development.
This gene has been implicated in two human pathological
conditions: orofacial cleft and schizophrenia. Davies et al. [2]
reported OFCC1 as a potential orofacial cleft susceptibility gene in
humans, based on the observation of three unrelated patients with
orofacial cleft, all harboring a chromosomal break within or close
to the uncharacterized OFCC1 gene. Schizophrenia is a severe and
debilitating mental illness that afflicts approximately 1% of the
world population. While the exact genetic mechanisms of disease
pathology remain elusive, recent progress in large-scale analyses
has isolated a number of potentially predisposing loci or genes.
Human chromosome 6p21–24 has repeatedly been identified as a
linkage locus for schizophrenia susceptibility [3,4,5].
Straub et al. analyzed an Irish family cohort, and identified the
DTNBP1 gene [coding for the dystrobrevin binding protein 1
(dysbindin)] from 6p22.3 as a schizophrenia susceptibility gene [6].
Forty nine families in their sample (18% of total) gave a positive
linkage signal at 6p24, when the twenty-seven 6p22.3-linked
families (10% of total) were omitted from the analysis. This raises
the possibility that the locus harbors more than one schizophrenia
susceptibility gene [7]. Follow-up analysis by Straub et al. on 262
Irish schizophrenic pedigrees identified a second gene, MRDS1/
PLoS ONE | www.plosone.org 1 December 2011 | Volume 6 | Issue 12 | e29499OFCC1 (encoding orofacial cleft 1 candidate 1) gene, located on
6p24.3, as a potentially novel candidate gene for schizophrenia
[8,9]. The positive association of schizophrenia with DTNBP1 has
been replicated in independent studies [10,11,12,13,14,15,
16,17,18,19,20], but association with the MRDS1/OFCC1 gene
has not been tested in other ethnic populations.
In this study, we first investigated the relationship between
MRDS1/OFCC1 and normal craniofacial and eye development, as
well as schizophrenia, by generating and examining mice deficient
in the gene corresponding to human MRDS1/OFCC1 and medaka
opo. In addition, we tested the hypothesis of genetic association
between the MRDS1 and schizophrenia using family-based
association analysis, in a Japanese cohort.
Methods
RACE analysis
39-RACE was performed using Mouse 15-day Embryo
Marathon-ready cDNA (Clontech, Mountain View, CA) following
manufacturer’s instruction. Gene specific forward primers used
were: mOfcc1-F1 (59-CAGCAGAAGGCTGTGAAGCAAAC-
TAAGCAG-39 in exon 3), mOfcc1-F2 (59-GTGAAGCAAAC-
TAAGCAGAAGAAATCCACG-39 in exon 3), and mOfcc1-F3
(59-AGAAGAAATCCACGTCGGCTGAATTTCTGA-39 in ex-
on 3). Amplified fragments were cloned into the pCR4-TOPO
vector (Invitrogen, Carlsbad, CA), and sequenced. Complimentary
DNA corresponding to the full-length open reading frames for
Mrds1/Ofcc1 variants 1 and 2 were amplified by polymerase chain
reaction (PCR) from mouse 15-day Marathon-ready cDNA
(Clontech), and then cloned into the XhoI/SalI site of the
pAcGFP1-C1 vector (Clontech), to examine cellular localization
of the protein.
Generation of knockout mouse
All animal experiment protocols were approved by the Animal
Experiment Committee of RIKEN Brain Science Institute and
BioResouce Center. Mice were housed in groups of four or five in
standard cages in a temperature and humidity controlled room,
with a 12-h light/dark cycle (lights on at 08:00), and had access to
standard lab chow and water ad libitum. The animals were used for
behavioral tests from 3 to 4 months of age.
Major experimental tasks (design and construction of targeting
vector, establishment of targeted ES cells, generation of the
chimera and F1 mice, and removal of the neo cassette) to generate
the Mrds1/Ofcc1 knockout mice were performed by Unitech, Co.
(Kashiwa, Japan). The knockout mice were produced on a
background of C57BL/6. The founder mouse (+/Flox [neo+])
was crossed with the FLPe transgenic mouse, producing
conditional knockout mice without the neo cassette (+/Flox
[neo-]). Deletion of this cassette was confirmed by PCR. In this
study, we created mice with a constitutionally deleted (KO) allele
by crossing the +/Flox [neo-] mice with the CAG-Cre-Tg mouse,
that systemically expresses Cre recombinase, under the control of
a CAG promoter [21]. After backcrosses for at least four
generations to C57BL/6N Slc (Japan SLC, Shizuoka, Japan),
heterozygotes were intercrossed to obtain wild-type (WT),
heterozygote and KO mice. Genotyping was performed by PCR
with primer sets: (forward 1: 59-CATGTGTACAGAACA-
TGTGTGTAGC-39, forward 2: 59-AGCTCCTCTATTCTC-
TGGTTGAGG-39, and reverse: 59-AGGTAGAGGCTCCTC
TGAGCTTAG-39). Template DNA was extracted from tails or
other tissues in some cases, producing 190 bp (forward 1 and
reverse primers) and 270 bp (forward 2 and reverse primers)
products from the WT and KO alleles, respectively.
To confirm the loss of Mrds1/Ofcc1 mRNA transcripts, total
RNA was extracted from E14.5 embryos using miRNeasy Mini
(Qiagen, Hilden, Germany), and the first strand cDNA synthesized
by oligo dT primer, was used as a template for RT-PCR. When
necessary, nested (2nd) PCR was performed to detect specific
bands. Primer pairs were: for the 1st PCR between the exons 3
and 4, 59-GAGAAGTTTCAGCAGAAGGCTGT-39 and 59-
ATGAGAAGAGCAGCAAGTGTGAG-39, for the 2nd PCR
between the exons 3 and 4, 59-GAAGGCTGTGAAGCAAAC-
TAAGC-39 and 59-GAGCACAATCAGGACTGAAGTCA-39,
for the PCR between the exons 3 and 6, 59-GAAGGCTGT-
GAAGCAAACTAAGC-39 and 59-TGATGAAGAACCTGCA-
AGCAG-59, and for the PCR between the exons 18 and 21, 59-
AAAGATCTGAGCAGTGGAGAGG-39 and 59-TTTCCAC-
TCGGGTTAATGATCT-39.
Behavioral Analyses
Behavioral analyses were performed as described elsewhere
[22,23,24]. All values in the text and figures represent mean 6
SEM (n=10–15/group). We analyzed the data using Student’s t-
test, and showed P values for comparisons between knockout
animals and their control littermates. P,0.05 was considered
significant. ANOVA (analysis of variance) followed by post hoc
Tukey multiple comparison test was also used if required.
Bone staining
Bone staining of E18.5 fetuses was performed as described [25],
using Alzarin Red S (Sigma, St. Luis, MO) and Alcian Blue 8GS
(Sigma, St. Luis, MO) for bone and cartilage, respectively.
The Japan Mouse Clinic
The knockout mice were screened for abnormalities using
systematic mouse abnormality screening called the ‘Japan Mouse
Clinic’, a research system established and performed at the
RIKEN BioResource Center (http://www.brc.riken.jp/lab/jmc/
mouse_clinic/m-strain_jp.html). In this study, we analyzed the
heterozygotes obtained by the intercross between heterozygous
animals (backcrossed animals) as well as KO animals and WT
littermates.
Human DNA sample
All subjects were recruited from a geographic area located in
central Japan. The family-based study samples consisted of 124
families with 376 individuals, of whom 163 subjects were
schizophrenics and the remainder, unaffected. The types and
numbers of families included 80 independent and complete trios
(schizophrenic offspring and their parents), 15 probands with one
parent, 13 probands with affected siblings, and 30 probands with
discordant siblings. Best-estimate lifetime diagnosis was made by
direct interview with at least two experienced psychiatrists and
based on DSM-IV criteria, using all available information from
medical records, hospital staff and family informants. Written
informed consent was obtained from all participants and the study
protocol was approved by the Committee on Ethics at RIKEN.
Genotyping of human subjects and statistical analyses
The genomic structure of human MRDS1/OFCC1 is based on
Human Feb. 2009 (GRCh37/hg19) of the UCSC database
(http://genome.ucsc.edu/) (Fig. S1). The single nucleotide poly-
morphism (SNP) search was performed using Entrez SNP from the
NCBI database (http://www.ncbi.nlm.nih.gov/SNP/). We select-
ed 32 SNPs within the MRDS1/OFCC1 gene, including SNPs that
showed strong evidence of association with schizophrenia in a
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PLoS ONE | www.plosone.org 2 December 2011 | Volume 6 | Issue 12 | e29499Figure 1. Identification of Mrds1/Ofcc1 transcripts in mice and design of the targeting vector. A. Multiple alignment of Mrds1/Ofcc1
amino-acid sequences from different vertebrates. The homologous N-terminal regions of the Mrds1/Ofcc1/MRDS1/OFCC1 proteins were aligned
using Genetyx-SV/RC (Ver. 15) software. B. Schematic view of the mouse Mrds1/Ofcc1 gene structure. Structures of the three newly identified isoforms
(variants 1, 2 and 3) are shown. White and black boxes show non-coding and coding exons, respectively. The structure of mouse Opo A is aligned with
that of Mrds1/Ofcc1. The structure of the targeting vector, targeted and KO alleles are also shown. C. Cellular localization of Mrds1/Ofcc1-EGFP. MEF
cells were transfected with plasmid expressing either variant 1-EGFP or variant 2-EGFP. EGFP signals (green) are shown with DAPI nuclear staining
(blue). Two typical cells are shown for each variant: variant 1-EGFP protein localizes in a relatively diffuse manner within the cytoplasm (upper left
panel) and, in part, as a net-like structure (lower left panel) in MEF cells. In contrast, the majority of variant 2-EGFP localizes as dot- or vesicle-like
structures in the cytoplasm (upper right panel). Nuclear localization is also evident in the cells with strong expression of variant 2-EGFP (lower right
panel).
doi:10.1371/journal.pone.0029499.g001
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genotyped and showed sufficient heterozygosity (minor allele
frequency .0.1) in our preliminary examinations were used for
further analyses (Table S1 and Figure S1). MRDS1/OFCC1 SNPs
span a genomic stretch of 483,168 bp and the average marker-to-
marker interval was ,20 kb. These SNPs were selected to cover
the MRDS1/OFCC1 region as evenly as possible.
DNA was extracted from whole blood according to a standard
protocol. We used Assays-by-Design SNP genotyping products to
score SNPs (Applied Biosystems, Carlsbad, CA, USA) (http://
www.appliedbiosystems.com/), based on the TaqMan assay
methods. Genotypes were determined using an ABI7900 sequence
detection system instrument (Applied Biosystems) and the SDS
v2.0 software package (Applied Biosystems).
The normalized LD coefficient D9 [26] and squared correlation
coefficient r
2 [27], parameters indicating a degree of LD between
markers, were calculated, and haplotype structures were con-
structed, using HAPLOVIEW version 4.2 (http://www.broad.mit.
edu/mpg/haploview/) [28]. Transmission distortions in the family
panel were evaluated using the pedigree disequilibrium test (PDT)
program, v5.1 (http://www.chg.duke.edu/research/software.html)
[29–30]. The PDT program computes two statistical measures,
PDT-sum and PDT-ave. Briefly, PDT-sum gives more weight to
largerfamilies,whereasPDT-ave placesequalweightonallfamilies.
The suitability of both statistical methods depends on family
structure and genetic models [29].
Results
Isolation of mouse Mrds1/Ofcc1 transcripts
The N-terminal region of the Ofcc1/Mrds1 protein is evolution-
arily conserved among vertebrates including human, mouse, turkey
and medaka fish (Figure 1A). However, the genomic structure of
mouse Mrds1/Ofcc1 is still unclear, particularly the 39 region. We
thus performed 39-rapid amplification of cDNA ends (RACE)
analysis with PCR primers placed in the conserved 59 region. Three
Mrds1/Ofcc1 isoforms were isolated: variants 1, 2 and 3 (Figure 1B)
with open reading frames (ORF) of 498 bp, 651 bp and 825 bp,
respectively. The deduced amino-acid sequences of the 3 variants
were not homologous to any known mouse proteins. Importantly,
we found that while exons 2 through 8 of Mrds1/Ofcc1 are shared
with the mouse Opo gene [31], exons 1 (non-coding) and 9 were not
(Figure 1B), suggesting that Mrds1/Ofcc1 variants 1, 2 and 3 are
shorter isoforms of the mouse Opo transcript.
Next, we examined cellular localization of Mrds1/Ofcc1
protein in mouse embryonic fibroblast (MEF) cells transfected
with an expression vector for either variant 1 or 2 tagged with
enhanced green fluorescent protein (EGFP) at the C-terminus.
The variant 1-EGFP construct showed diffuse expression in the
cytoplasm, in a partial net-like structure within MEF cells. In
contrast, the majority of the variant 2-EGFP protein was localized
as dot or vesicle like structures in the cytoplasm. Nuclear
localization was also evident in cells with high expression of the
variant 2-EGFP construct (Figure 1C).
Generation of Mrds1/Ofcc1 knockout (KO) mice
We created two different types of KO mouse, systemic and
conditional. In the conditional knockout alleles of the gene, exons
3 and 4 of the Mrds1/Ofcc1 gene are flanked by two loxP sequences
(Figure 1B). In this study, we analyzed the (systemic) KO mice,
which were created by mating mice with conditional KO alleles
with transgenic (Tg) mice expressing Cre recombinase (Figures 1B
and 2A). The homozygous KO mice were born according to the
Mendelian ratio and grew normally to adulthood (data not shown).
RT-PCR analysis using primer pairs designed between exons 3
and 4, and exons 3 and 6 showed a lack of transcripts for variants
1, 2 and 3 in the whole brain and trunk from embryonic day 14.5
(E14.5), KO embryos (Figure 2B, left and middle panels). As
expected, mRNA expression in KO mice was detected with
primer sets between exons 18 and 21 (Figure 2B, right panel).
Deletion of exons 3 and 4, in all likelihood created out-of-frame
(frame-shifted) transcripts (Figure 1B), producing biologically
inactive proteins in the mutant mice.
No craniofacial abnormalities in the KO mice
No orofacial clefts (cleft lip and/or cleft palate) were found in
the greater than 50 examined mutant mice. There were no
discernible differences between the typical appearance of WT and
KO faces (Figure 3A). Nor did the head skull structures of the
E18.5 KO fetuses differ from those of the control mice (Figure 3B).
Figure 2. Transcript characterization of Mrds1/Ofcc1 KO mice. A. Genotyping. Genotypes of the mice were determined by PCR. A typical gel
image is shown. L: size marker B. Loss of mRNA for variants 1, 2 and 3, in the KO mice. Total RNA extracted from the E14.5 embryos (brain and trunk)
was analyzed by RT-PCR and typical gel images are shown. Exon pairs in which specific primers were set are indicated above the gel images. Positions
of specific bands are denoted by arrowheads. L: size marker.
doi:10.1371/journal.pone.0029499.g002
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-induced mutation disrupts normal splicing of the opo gene, which
is a potential ortholog for mouse and human Mrds1/Ofcc1/
MRDS1/OFCC1, develops the ojoplano (‘flat eye’) phenotype due to
defective eye cup morphogenesis [1]. No apparent eye abnormal-
ities were observed in our KO mice (Figure 3 A and C), although
we did not perform histological or immunohistochemical exam-
inations. These data indicate that penetrance of the craniofacial
abnormality generated by the deficiency of Mrds1/Ofcc1 is, if
existent, extremely low in mice.
Genetic association of MRDS1/OFCC1 with schizophrenia,
but with no disease related behavioral abnormalities in
KO mice
We examined whether the KO mice exhibited behavioral
changes related to mental illnesses, including schizophrenia. We
used a battery of tests consisting of open field, tail suspension,
elevated plus maze, home cage activity, prepulse inhibition (PPI),
and fear conditioning tests. Results are summarized in Table 1 and
Figure 4. Importantly, we detected no differences between WT
and KO in PPI [two-way repeated ANOVA (prepulse level x
genotype), genotype effect, male, F(1,42) =0.761, P=0.388; female,
F(1,44) =0.102, P=0.751], a test of sensorimotor gating function
(Figure 4A), although deficits in PPI have been reported in patients
with schizophrenia. In addition, tests on our KO mice related to
affection and cognition axes detected no behavioral changes which
correlate with phenotypes seen in human mental disorders
(Figure 4B and Table 1).
In contrast to results from animal studies, we found an
association between schizophrenia and MRDS1/OFCC1 in a
Japanese cohort. Five SNPs that span a 197 kb region of the
gene (rs7741209–rs855394), showed significant transmission
distortion in a family-based association study (lowest P=0.0082
for rs7741209) (Figure S1 and Table S1). Pairwise marker-to-
marker linkage disequilibrium (LD) and haplotype block structures
based on the standard Lewontin D9 statistic and squared
correlation coefficient r
2 statistic are shown (Figure S2, A and B).
The SNPs that showed significant association with schizophrenia
were not in tight LD to each other (Figure S2, A and B). This may
reflect an allelic heterogeneity of the gene that confers suscepti-
bility to schizophrenia in the Japanese population.
Significant increase in serum c-glutamyl transpeptidase
(GGT) levels in KO mice
To obtain insight into the biological function of Mrds1/Ofcc1,w e
analyzed the KO mice using the ‘Japan Mouse Clinic’, a
comprehensive and systematic abnormality screening system
conducted by the RIKEN BioResource Center [32] (http://
www.brc.riken.jp/lab/jmc/mouse_clinic/m-strain_jp.html). This
system analyzes mice in a two-step manner, via pipeline 1 and
pipeline 2. Tests in pipeline 1 are categorized into two groups,
fundamental and in-depth screens. The fundamental screen is
performed using six methods: the open field test, modified
SHIRPA (SmithKline Beecham Pharmaceuticals; Harwell, MRC
Mouse Genome Centre and Mammalian Genetics Unit; Imperial
College School of Medicine at St Mary’s; Royal London
Hospital, St Bartholomew’s and the Royal London School of
Medicine; Phenotype Assessment), hematological tests, urinalysis,
clinical biochemical tests and a macroscopic test. The in-depth
screen is performed using 11 methods: rotarod test, auditory
brain stem response (ABR), insulin tolerance test (ITT), oral
glucose tolerance test (OGTT), lactate measurements in blood,
adipokines and clinical biochemical tests (glucose and adipose
related), fundoscopy, ERG (electroretinography), blood pressure,
body fat percentage, bone mineral density (by DEXA; dual-
energy X-ray absorptiometry) and echocardiography. The
extensive pipeline 1 screen revealed that two measures were
significantly different among the genotypes: c-glutamyl transpep-
tidase (GGT) levels (Figure 5A) and ‘tail ratio’ (a ratio of body
length to tail length) [Figure S3, WT vs. heterozygote (HET),
P=0.02 by Tukey multiple comparison]. Levels of GGT, which
are measured in the ‘clinical biochemical test (lipid and glucose)’,
were markedly higher in KO mice compared to WT and HET
mice of either sex [Two-way ANOVA (genotype x sex), genotype
effect, F(2,44) =10.449, P=0.00019; post hoc Tukey multiple
comparison, HET vs. KO, P=0.00034, WT vs. KO, P=0.0011]
(Figure 5A).
GGT is a reliable and established marker for liver function in
human clinical practice. However, we did not find any other
markers suggesting liver dysfunction in serum or (Figure 5, B-D)i n
liver tissue (data not shown). In humans, elevated levels of GGT
are seen in the early phase of alcoholic hepatopathy. Additionally,
human kidney and pancreas are GGT enriched tissues, but we
found no evidence suggesting abnormalities of these two organs in
Figure 3. Mrds1/Ofcc1-deficient mice do not show any cranio-
facial or eye malformations. A. Facial appearance. Frontal (upper
panels) and ventral views (lower panels) are shown. B.Headskullstructure.
E18.5 mice were sacrificed and stained with Alcian Blue (blue) and Alizarin
Red (red) for cartilage and bone, respectively. C. Eyeball structure. Eyeballs
were removed from adult mice and then photographed.
doi:10.1371/journal.pone.0029499.g003
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the KO mice have notably increased serum levels of GGT. To our
knowledge, this is the first report of asymptomatic hyper-c-
glutamyl transpeptidasemia in mice.
Pipeline 2 is a behavior-oriented screen, consisting of light/dark
transition, open-field, home-cage activity, passive avoidance, tail
suspension, hot plate and tail flick tests. We detected no significant
differences among the three genotypes, WT, HET and KO in
these tests. The optional three tests, PPI, object exploration and
fear conditioning tests were not performed.
Discussion
The MRDS1/OFCC1/Mrds1/Ofcc1/Opo gene is structurally
conserved among vertebrates, suggesting a phylogenically impor-
tant role for this gene. In this study, we created and analyzed
Mrds1/Ofcc1 KO mice, where the gene construct lacks exons 4 and
5, generating a frame-shift mutation in the mRNA and thereby
producing a premature termination codon that potentially
abolishes the biological activity of the protein. Mice were analyzed
thoroughly using amongst other tests, the Japan Mouse Clinic, a
systematic abnormality screening system for mutant mice. Despite
its genetic involvement in craniofacial and eye development and
the pathogenesis of schizophrenia, no discernible abnormalities in
mutant mice were detected, except for surprisingly high levels of
GGT in the sera. A possible explanation for these results is that an
as yet unidentified gene with structural homology to Mrds1/Ofcc1
compensates for the loss of the Mrds1/Ofcc1 at a functional level.
This is however unlikely, as an extensive homology search of the
database by researchers including ourselves, has failed to identify
any gene homologous to Mrds1/Ofcc1 in the mouse genome.
In medaka fish, a hypomorphic mutation in Opo, results in
multiple malformations of craniofacial structures, including the
eyes. It is possible that the function of mammalian Mrds1/Ofcc1/
MRDS1/OFCC1 differs from that of medaka Opo. It is also possible
that the genetic background of mice may influence the penetrance
of the predicted eye phenotypes. Alternatively, one or more
biologically active, uncharacterized transcripts that do not include
exons 4 and 5 may be present. In this study, we detected a
transcript containing exons 18 through 21, in the KO mice
(Figure 2B, right panel). This scenario seems unlikely as medaka
opo proteins are expressed as two isoforms of 42 and 130 kDa [1],
and a hypomorphic mutation of the gene results in a reduction of
the two proteins.
As stated earlier, OFCC1 is also a positional candidate gene for
orofacial cleft (OFC1, OMIM119530). However, we detected no
abnormalities in craniofacial development in the KO mice.
Although we cannot rule out the possibility that abrogated
MRDS1/OFCC1/Mrds1/Ofcc1 is insufficient to cause craniofacial
abnormalities, the simplest explanation for the current observation
is that MRDS1/OFCC1 is not a causal gene for orofacial cleft seen
in subjects with a chromosomal break at 6p24. Consistent with this
idea, is the identification of the other candidate gene for OFC1
locus, TFAP2A [2] which lies proximal to MRDS1/OFCC1. While
this gene does not appear to be directly disrupted by chromosomal
breaks in the three affected subjects, Tfap2a knockout mice exhibit
pleiotropic morphological abnormalities, including orofacial cleft
[33].
Table 1. Summary of behavioral analyses of Mrds1/Ofcc1 KO mice.
Male Female
Test battery WT KO
P (Student’s
t-test) WT KO
P (Student’s
t-test)
OF Total distance (cm /10min) 3112.36166.9 3490.56212.4 0.1688 3547.26203.4 3881.76149.1 0.1916
Center time (cm /10 min) 104.8614.9 124.1616 0.3824 90.767.0 90611.6 0.959
EPM Open arm stay time (%) 17.863.5 17.664.9 0.9737 19.464.7 29.665.0 0.1443
Closed arm stay time (%) 82.363.5 82.564.9 0.9737 80.764.7 70.565.0 0.1443
Total distance (cm) 738.7642.9 770.0644.4 0.6148 753.2649.4 838.1657.6 0.2693
LD Stay time (L) (sec/10 min) 529.069.6 531.566.9 0.8335 548.268.8 534.1610.2 0.301
Stay time (D) (sec/10 min) 81.069.7 78.567.4 0.8377 61.369.0 75.1610.4 0.3212
Transition numbers 14.061.7 13.761.5 0.8954 10.761.6 12.061.6 0.5685
Latency (D to L) (sec/10 min) 112.7620.9 124.3621.5 0.7008 109.6621.1 100.0624.3 0.7669
PPI 74/120 dB % 21.364.5 28.865.5 0.388* 35.564.9 29.264.2 0.751*
(prepulse level/
pulse level)
80/120 dB % 25.666.4 32.464.2 37.064.3 39.563.8
86/120 dB % 41.763.5 42.463.5 44.964.4 43.464.2
ASR 1212.1672.6 1137.8660.3 0.4338 884.2694.0 965.7679.2 0.5108
FST Immobility time (sec/5min) 146.069.1 130.668.2 0.211 149.168.3 164.267.7 0.1892
TST Immobility (%) 15.463.1 18.262.4 0.5341 25.866.6 18.764.0 0.3626
HCA Locomotor activity (x10
4)7 . 6 60.6 7.461.5 0.8947 9.261.9 12.361.1 0.1814
FC Conditioning (freezing %) 29.263.0 22.662.4 0.0916 16.061.6 14.961.8 0.6501
Contextual test (freezing %) 71.664.0 63.864.0 0.1752 52.664.1 58.764.0 0.2927
Cued test (freezing %) 62.463.2 62.663.9 0.9686 48.464.4 54.964.2 0.2911
OF; the open field test; EPM: elevated puls maze test; LD: light and dark box transition test; PPI: prepulse inhibition test; FST: forced swim test; TST: tail suspension test;
HCA: home cage activity test; FC: fear conditioning test; ASR: acoustic startle response without prepulse. *Statistical analysis for PPI was performed by two-way repeated
ANOVA between multiple prepluse levels and genotypes. All values represent mean 6 SEM (n=10–15/group).
doi:10.1371/journal.pone.0029499.t001
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PLoS ONE | www.plosone.org 7 December 2011 | Volume 6 | Issue 12 | e29499Interestingly, our KO mice exhibited strikingly high levels of
GGT in sera. This phenotype of high but asymptomatic levels of
GGT has not been reported previously in mammals. None of the
examined schizophrenic offspring showed extremely high levels of
GGT in the absence of other markers for tissue damage. Discovery
of this asymptomatic, high c-glutamyl transpeptidasemia pheno-
type would have been difficult, without the availability of the
Japan Mouse Clinic, a research tool established by our institute.
This discovery could assist in identifying corresponding human
subjects in a clinical setting. Examining the relationship between
schizophrenia and liver function-related parameters, some patients
with schizophrenia manifest asymptomatic hyperbilirubinemia
[34]. However, our KO mice showed normal levels of bilirubin.
Recent studies have found the relationship GGT levels and
cardiovascular diseases independent on the liver function,
although we found no sign for cardiovascular defect in the KO
mice [35,36].
In this study of KO mice, we were unable to identify any
schizophrenia-relevant behavioral abnormalities. It may be
interesting to examine how the behavior of the KO mice is
modulated when they are placed under stress-loaded conditions
such as separation of pups from dams or administrated with
Figure 4. Behavioral tests for Mrds1/Ofcc1 KO mice. A. Prepulse inhibition (PPI) test. Prepulse and pulse levels are shown under the X-axis. The
acoustic startle response (ASR) at 120 dB is also shown (right). Blue and red bars show WT and KO mice, respectively. B. The open field test. Blue and
red lines show WT and KO mice, respectively.
doi:10.1371/journal.pone.0029499.g004
Figure 5. Significant increase in c-glutamyl transpeptidase expression in KO mice. A, B, C, and D. Liver-related measures derived from
serum examined in the Japan Mouse Clinic are shown in A (GGT: c-glutamyl transpeptidase), B (AST: asparagine transferase), C (ALT: alkaline
phosphatase), and D (LDH: lactic dehydrogenase). ns, not significant.
*P,0.01,
**P,0.001 by Tukey multiple comparison.
doi:10.1371/journal.pone.0029499.g005
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PLoS ONE | www.plosone.org 8 December 2011 | Volume 6 | Issue 12 | e29499psychostimulants like methamphetamine. In the human study, we
have found evidence of a genetic association between the MRDS1/
OFCC1 gene and schizophrenia in a Japanese sample. To
corroborate this association, further studies using larger sample
sizes will be needed.
Finally, future analysis of our Mrds1/Ofcc1-KO mice could be
valuable in deciphering the mechanism of high c-glutamyl
transpeptidasemia and its possible relationship to schizophrenia.
Supporting Information
Figure S1 Genomic structure of the MRDS1/OFCC1
gene and gene-centric association analysis. Genomic
structure of the MRDS1/OFCC1 gene is shown with chromosomal
positions according to the human genome database (http://
genome.ucsc.edu/). The negative logarithm of P value for
association is plotted as a function of the order of SNP markers.
Statistical analyses were performed using the pedigree disequilib-
rium test. Red diamond-shaped marks denote SNPs with P,0.05,
while blue marks denote SNPs with P.0.05.
(EPS)
Figure S2 Pairwise marker-to- marker linkage disequi-
librium structure in Japanese samples. (A and B) The
standard Lewontin D9 statistic (A), and the squared correlation
coefficient r
2 statistic (B) are shown. Bold SNPs are those
associated with schizophrenia.
(EPS)
Figure S3 The ‘tail ratio’ in knockout mice.
(EPS)
Table S1 Summary of genetic association study. SNP ID:
Entrez SNP database (http://www.ncbi.nlm.nih.gov/snp) Posi-
tion: Based on the UCSC Genome Browser on Human Feb. 2009
(GRCh37/hg19) Assembly (http://genome.ucsc.edu/) SUM:
PDT-SUM statistics, AVE: PDT-AVE statistics.
(DOC)
Acknowledgments
We thank Dr. Miyazaki (Osaka University) for the kind gift of the CAG-
Cre-Tg mice. We are grateful to all staff within the Japan Mouse Clinic.
We are also grateful to members of the Research Resources Center of
RIKEN BSI for animal care, sequencing service and other technical
support.
Author Contributions
Conceived and designed the experiments: TO SDD-W KW TY.
Performed the experiments: TO KY AW HO TS YH YI MM. Analyzed
the data: TO KY AW KW SW. Contributed reagents/materials/analysis
tools: SW TT. Wrote the paper: TO KY TY.
References
1. Martinez-Morales JR, Rembold M, Greger K, Simpson JC, Brown KE, et al.
(2009) ojoplano-mediated basal constriction is essential for optic cup morpho-
genesis. Development 136: 2165–2175.
2. Davies SJ, Wise C, Venkatesh B, Mirza G, Jefferson A, et al. (2004) Mapping of
three translocation breakpoints associated with orofacial clefting within 6p24
and identification of new transcripts within the region. Cytogenet Genome Res
105: 47–53.
3. Purcell SM, Wray NR, Stone JL, Visscher PM, O’Donovan MC, et al. (2009)
Common polygenic variation contributes to risk of schizophrenia and bipolar
disorder. Nature 460: 748–752.
4. Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, et al. (2009)
Common variants conferring risk of schizophrenia. Nature 460: 744–747.
5. Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, et al. (2009) Common
variants on chromosome 6p22.1 are associated with schizophrenia. Nature 460:
753–757.
6. Straub RE, Jiang Y, MacLean CJ, Ma Y, Webb BT, et al. (2002) Genetic
variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse
dysbindin gene, is associated with schizophrenia. Am J Hum Genet 71: 337–348.
7. Straub RE, Weinberger DR (2006) Schizophrenia genes - famine to feast. Biol
Psychiatry 60: 81–83.
8. Straub RE, Matsumoto M, Egan MF, Goldberg TE, Callicott JH, et al. (2003)
MRDS1 (6p24.3) is associated with schizophrenia in both adult onset and
childhood onset schizophrenia families. Am J Med Genet 122B: 18.
9. Matsumoto M, Weinberger DR, Straub RE (2002) Molecular cloning,
sequencing, and characterization of a novel 500 kilobase gene (MRDS1) from
6p24, a schizophrenia candidate region. Am J Med Genet 114B: 857.
10. Schwab SG, Knapp M, Mondabon S, Hallmayer J, Borrmann-Hassenbach M,
et al. (2003) Support for association of schizophrenia with genetic variation in
the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional
sample of triad families. American journal of human genetics 72: 185–190.
11. Kirov G, Ivanov D, Williams NM, Preece A, Nikolov I, et al. (2004) Strong
evidence for association between the dystrobrevin binding protein 1 gene
(DTNBP1) and schizophrenia in 488 parent-offspring trios from Bulgaria.
Biological psychiatry 55: 971–975.
12. Williams NM, Preece A, Morris DW, Spurlock G, Bray NJ, et al. (2004)
Identification in 2 independent samples of a novel schizophrenia risk haplotype
of the dystrobrevin binding protein gene (DTNBP1). Archives of general
psychiatry 61: 336–344.
13. Tochigi M, Zhang X, Ohashi J, Hibino H, Otowa T, et al. (2006) Association
study of the dysbindin (DTNBP1) gene in schizophrenia from the Japanese
population. Neuroscience research 56: 154–158.
14. Holliday EG, Handoko HY, James MR, McGrath JJ, Nertney DA, et al. (2006)
Association study of the dystrobrevin-binding gene with schizophrenia in
Australian and Indian samples. Twin research and human genetics : the official
journal of the International Society for Twin Studies 9: 531–539.
15. Li T, Zhang F, Liu X, Sun X, Sham PC, et al. (2005) Identifying potential risk
haplotypes for schizophrenia at the DTNBP1 locus in Han Chinese and Scottish
populations. Molecular psychiatry 10: 1037–1044.
16. Funke B, Finn CT, Plocik AM, Lake S, DeRosse P, et al. (2004) Association of
the DTNBP1 locus with schizophrenia in a U.S. population. American journal
of human genetics 75: 891–898.
17. Turunen JA, Peltonen JO, Pietilainen OP, Hennah W, Loukola A, et al. (2007)
The role of DTNBP1, NRG1, and AKT1 in the genetics of schizophrenia in
Finland. Schizophrenia research 91: 27–36.
18. Vilella E, Costas J, Sanjuan J, Guitart M, De Diego Y, et al. (2008) Association
of schizophrenia with DTNBP1 but not with DAO, DAOA, NRG1 and RGS4
nor their genetic interaction. Journal of psychiatric research 42: 278–288.
19. Riley B, Kuo PH, Maher BS, Fanous AH, Sun J, et al. (2009) The dystrobrevin
binding protein 1 (DTNBP1) gene is associated with schizophrenia in the Irish
Case Control Study of Schizophrenia (ICCSS) sample. Schizophrenia research
115: 245–253.
20. Zuo L, Luo X, Kranzler HR, Lu L, Rosenheck RA, et al. (2009) Association
study of DTNBP1 with schizophrenia in a US sample. Psychiatric genetics 19:
292–304.
21. Sakai K, Miyazaki J (1997) A transgenic mouse line that retains Cre recombinase
activity in mature oocytes irrespective of the cre transgene transmission.
Biochemical and biophysical research communications 237: 318–324.
22. Ohnishi T, Watanabe A, Ohba H, Iwayama Y, Maekawa M, et al. (2010)
Behavioral analyses of transgenic mice harboring bipolar disorder candidate
genes, IMPA1 and IMPA2. Neurosci Res 67: 86–94.
23. Watanabe A, Toyota T, Owada Y, Hayashi T, Iwayama Y, et al. (2007) Fabp7
maps to a quantitative trait locus for a schizophrenia endophenotype. PLoS Biol
5: e297.
24. Yoshikawa T, Watanabe A, Ishitsuka Y, Nakaya A, Nakatani N (2002)
Identification of multiple genetic loci linked to the propensity for ‘‘behavioral
despair’’ in mice. Genome Res 12: 357–366.
25. McLeod MJ (1980) Differential staining of cartilage and bone in whole mouse
fetuses by alcian blue and alizarin red S. Teratology 22: 299–301.
26. Lewontin RC (1988) On measures of gametic disequilibrium. Genetics 120:
849–852.
27. Devlin B, Risch N (1995) A comparison of linkage disequilibrium measures for
fine-scale mapping. Genomics 29: 311–322.
28. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and
visualization of LD and haplotype maps. Bioinformatics 21: 263–265.
29. Martin ER, Bass MP, Kaplan NL (2001) Correcting for a potential bias in the
pedigree disequilibrium test. Am J Hum Genet 68: 1065–1067.
30. Martin ER, Monks SA, Warren LL, Kaplan NL (2000) A test for linkage and
association in general pedigrees: the pedigree disequilibrium test. American
Journal of Human Genetics 67: 146–154.
31. Mertes F, Martinez-Morales JR, Nolden T, Sporle R, Wittbrodt J, et al. (2009)
Cloning of mouse ojoplano, a reticular cytoplasmic protein expressed during
embryonic development. Gene Expr Patterns 9: 562–567.
32. Wakana S, Suzuki T, Furuse T, Kobayashi K, Miura I, et al. (2009) Introduction
to the Japan Mouse Clinic at the RIKEN BioResource Center. Experimental
animals / Japanese Association for Laboratory Animal Science 58: 443–450.
Analyses of Mrds1/Ofcc1 KO Mice
PLoS ONE | www.plosone.org 9 December 2011 | Volume 6 | Issue 12 | e2949933. Nottoli T, Hagopian-Donaldson S, Zhang J, Perkins A, Williams T (1998) AP-2-
null cells disrupt morphogenesis of the eye, face, and limbs in chimeric mice.
Proc Natl Acad Sci U S A 95: 13714–13719.
34. Radhakrishnan R, Kanigere M, Menon J, Calvin S, Janish A, et al. (2011)
Association between Unconjugated Bilirubin and schizophrenia. Psychiatry
research.
35. Fraser A, Harris R, Sattar N, Ebrahim S, Smith GD, et al. (2007) Gamma-
glutamyltransferase is associated with incident vascular events independently of
alcohol intake: analysis of the British Women’s Heart and Health Study and
Meta-Analysis. Arteriosclerosis, Thrombosis, and Vascular Biology 27:
2729–2735.
36. Mason JE, Starke RD, Van Kirk JE (2010) Gamma-glutamyl transferase: a novel
cardiovascular risk biomarker. Preventive cardiology 13: 36–41.
Analyses of Mrds1/Ofcc1 KO Mice
PLoS ONE | www.plosone.org 10 December 2011 | Volume 6 | Issue 12 | e29499